1.Inflammatory bowel disease in a young female patient with a novel de novo TRAF3 frameshift variant responsive to ustekinumab: a case report
Ichiro TAKEUCHI ; Kosuke TANIGUCHI ; Katsuhiro ARAI ; Toru UCHIYAMA ; Miho TERAO ; Asuka HORI ; Toshinao KAWAI ; Takako YOSHIOKA ; Reiko KYODO ; Hirotaka SHIMIZU ; Satoshi FUJITA ; Kenichiro MOTOMURA ; Yuka OKAZAKI ; Takashi ISHIKAWA ; Masao OGURA ; Kentaro HAYASHI ; Kenji MATSUMOTO ; Shuji TAKADA ; Masafumi ONODERA ; Hideaki MORITA ; Kenichiro HATA
Intestinal Research 2026;24(1):182-188
Tumor necrosis factor receptor-associated factor 3 (TRAF3) is an anti-inflammatory molecule that negatively regulates the non-canonical nuclear factor-κB pathway. Although TRAF3 haploinsufficiency (TRAF3 HI) can influence innate and adaptive immune cells, its effect on inflammatory bowel disease (IBD) development remains unclear. Here, we report the first case of severe early-onset IBD with a novel TRAF3 variant leading to HI, successfully treated with ustekinumab. A 6-year-old girl with a recurrent parotitis, otitis media, tonsilitis, and atopic dermatitis developed IBD involving the stomach, small intestine, and colon. At diagnosis, the immunoglobulin (Ig)G and IgA levels were relatively high, and lymphocyte subsets showed increased counts of plasmablasts, class-switch recombination B cells, and circulating T-follicular helper cells. Treatment with azathioprine and infliximab failed to maintain remission marked by several relapses accompanied by erythema nodosum and arthritis; however, ustekinumab, an anti-interleukin (IL)-12/23p40 antibody, led to long-term clinical remission, normalizing the Ig level and reducing abnormal lymphocyte counts. Whole-exome sequencing revealed a novel heterozygous mutation in TRAF3 [p.(Pro487Leufs*8)], resulting in TRAF3 under-expression. Our case may highlight the contribution of TRAF3 HI to the development of IBD and provide insights into IBD pathophysiology, suggesting the involvement of the IL-12/23-T-follicular helper cell pathway affected by genetic mutations.
2.Short-term surgical outcomes of robot-assisted colectomy for colon cancer using the hinotori Surgical Robot System
Koji MOROHARA ; Hidetoshi KATSUNO ; Tomoyoshi ENDO ; Kenji KIKUCHI ; Kenichi NAKAMURA ; Kazuhiro MATSUO ; Takahiko HIGASHIGUCHI ; Tetsuya KOIDE ; Tsunekazu HANAI ; Zenichi MORISE
Annals of Coloproctology 2025;41(1):97-103
3.Short-term surgical outcomes of robot-assisted colectomy for colon cancer using the hinotori Surgical Robot System
Koji MOROHARA ; Hidetoshi KATSUNO ; Tomoyoshi ENDO ; Kenji KIKUCHI ; Kenichi NAKAMURA ; Kazuhiro MATSUO ; Takahiko HIGASHIGUCHI ; Tetsuya KOIDE ; Tsunekazu HANAI ; Zenichi MORISE
Annals of Coloproctology 2025;41(1):97-103
4.Short-term surgical outcomes of robot-assisted colectomy for colon cancer using the hinotori Surgical Robot System
Koji MOROHARA ; Hidetoshi KATSUNO ; Tomoyoshi ENDO ; Kenji KIKUCHI ; Kenichi NAKAMURA ; Kazuhiro MATSUO ; Takahiko HIGASHIGUCHI ; Tetsuya KOIDE ; Tsunekazu HANAI ; Zenichi MORISE
Annals of Coloproctology 2025;41(1):97-103
5.Short-term surgical outcomes of robot-assisted colectomy for colon cancer using the hinotori Surgical Robot System
Koji MOROHARA ; Hidetoshi KATSUNO ; Tomoyoshi ENDO ; Kenji KIKUCHI ; Kenichi NAKAMURA ; Kazuhiro MATSUO ; Takahiko HIGASHIGUCHI ; Tetsuya KOIDE ; Tsunekazu HANAI ; Zenichi MORISE
Annals of Coloproctology 2025;41(1):97-103
6.Short-term surgical outcomes of robot-assisted colectomy for colon cancer using the hinotori Surgical Robot System
Koji MOROHARA ; Hidetoshi KATSUNO ; Tomoyoshi ENDO ; Kenji KIKUCHI ; Kenichi NAKAMURA ; Kazuhiro MATSUO ; Takahiko HIGASHIGUCHI ; Tetsuya KOIDE ; Tsunekazu HANAI ; Zenichi MORISE
Annals of Coloproctology 2025;41(1):97-103
7.Survey of the Use of Fibrinogen Concentrate during Cardiovascular Surgery in Japan
Akihiko USUI ; Hideyuki SHIMIZU ; Kenji MINATOYA ; Kenji OKADA ; Norihiko SHIIYA ; Noboru MOTOMURA ; Hitoshi YOKOYAMA
Japanese Journal of Cardiovascular Surgery 2023;52(5):353-360
Background: A review committee for unapproved and off-label drugs with high medical needs determined that the indication of fibrinogen concentrate for cardiovascular surgery would be publicly acceptable in 2021. However, the Japanese Society of Cardiovascular Surgery is required the conduct of several surveys demonstrating that fibrinogen concentrate can be used properly in medical settings. A questionnaire concerning the use of fibrinogen concentrate in cardiovascular surgery was one such required survey. Methods: A questionnaire concerning the use of fibrinogen concentrate was conducted in December 2021 at 551 certified training facilities of the Japanese Board of Cardiovascular Surgery, and responses were received from 375 facilities (68%). Results: Fibrinogen concentrate was used in 98 centers (26%). Aortic surgery (thoracic/thoracoabdominal) (50%) and cardiac redo surgery (24%) were eligible common surgeries requiring fibrinogen concentrate, and the intraoperative measurement of fibrinogen levels was performed in 77% of centers. The triggers for the use of fibrinogen concentrate were a fibrinogen level <150 mg/dl in 30%, <100 mg/dl in 20% and massive bleeding tendency in 40%. Of note, only 39 facilities (10%) were able to prepare cryoprecipitate in-hospital, and 34 centers (9%) used it for cardiovascular surgery. One hundred and seven centers (29%) planned to apply for facility accreditation for the use of fibrinogen concentrate, and 40 facilities (10%) answered that they would decide based on the situation. The expected number of annual cases in which fibrinogen concentrate would be used for cardiovascular surgery reached 4,860 cases: <10 cases in 52 centers, 10-19 cases in 50 centers, 20-49 cases in 31 centers, 50-99 cases in 12 centers and ≥100 cases in 2 centers. Conclusion: We conducted a questionnaire on the use of fibrinogen concentrate. Intraoperative fibrinogen level measurement was performed at approximately 80% of institutions, and the annual number of cases likely to use fibrinogen concentrate was predicted to reach about 5,000 cases. However, only 10% of centers used cryoprecipitates prepared in-hospital.
8.Committee report (Practice Article1) : Online Interprofessional Education
Interprofessional Education COMMITTEE ; Junji HARUTA ; Michiko GOTO ; Takahiko NOROSE ; Chikusa MURAOKA ; Miyuki INO ; Satoko ISHIKAWA ; Yasushi UCHIYAMA ; Masatsugu OHTSUKI ; Hirotaka KATO ; Ryohei GOTO ; Chisako NAITO ; Takami MAENO ; Kenji YOSHIMI ; Hiroki YASUI
Medical Education 2021;52(1):53-57
It is difficult to implement interprofessional education (IPE) in the classroom due to COVID-19. To share our knowledge of online IPE, we report on how we provided IPE for first-year students at two universities. At Mie University, a class was implemented to use Zoom. Quizzes and chats promoted interactions between instructors and students. At Hokkaido University of Science, an online team medical experience game was conducted via Zoom and a Learning Management System (LMS). The activity promoted interaction between students through gameplay and clear instructions. In both cases, students could successfully develop online IPE based on existing learning methods. Through their experience, it was clear that students are able to understand other professionals’ roles. They were also to commit to membership and/or teamship. On the other hand, students faced challenges with faculty familiarity and time allocation.
9.Working Group Report (Practice article 2) : Online Interprofessional Education Stepwise Interprofessional Education through Inter-University Collaboration at the University of Tsukuba (1)
The 21st - Term Interprofessional Education Committee ; Ryohei GOTO ; Takami MAENO ; Junji HARUTA ; Miyuki INO ; Satoko ISHIKAWA ; Yasushi UCHIYAMA ; Masatsugu OHTSUKI ; Hirotaka KATO ; Michiko GOTO ; Chisako NAITO ; Takahiko NOROSE ; Kenji YOSHIMI ; Hiroki YASUI
Medical Education 2021;52(6):557-563
For this second report, we divided the efforts of the University of Tsukuba into two parts. In the first part, we introduced the Interprofessional program, an inter-university collaborative educational program between the University of Tsukuba and Ibaraki Prefectural University of Health Sciences. Before the COVID-19 pandemic, this program was conducted using TBL (Team-based learning) in a large conference room. After the pandemic, this was conducted online (using Zoom). The main changes due to the online implementation were the following five points; (1) online faculty meetings, (2) advance distribution of materials, (3) testing using Google Forms, (4) group work using the breakout function, and (5) simultaneous editing using Google Docs. In the future, we would like to examine the possibility of new educational methods while creating innovations that are possible only through online interprofessional educational programs.
10.Working Group Report (Practice article 2) : Online Interprofessional Education Stepwise Interprofessional Education through Inter-University Collaboration at the University of Tsukuba (2)
Takami MAENO ; Ryohei GOTO ; Junji HARUTA ; Miyuki INO ; Satoko ISHIKAWA ; Yasushi UCHIYAMA ; Masatsugu OHTSUKI ; Hirotaka KATO ; Michiko GOTO ; Chisako NAITO ; Takahiko NOROSE ; Kenji YOSHIMI ; Hiroki YASUI
Medical Education 2021;52(6):565-570
In the second part of the second report, we introduce the Care Colloquium, an inter-university collaborative educational program between the University of Tsukuba and the Tokyo University of Science. The Care Colloquium is an interprofessional education program that uses PBL (Problem-based learning). In response to the COVID-19 pandemic, this program was implemented online using Microsoft Teams, with advance preparation including manual maintenance and communication testing. The same learning outcomes were achieved as the face-to-face implementation. Undergraduate interprofessional education tends to be a large-scale program, and the shortage of faculty and classrooms is challenging, but online education could overcome these obstacles. The development of hybrid programs that use the merits of both face-to-face and online education may lead to the promotion of interprofessional education in the future.


Result Analysis
Print
Save
E-mail